Akari Therapeutics Plc · NASDAQ:AKTX
Bazemore Robert B received 17,777 Akari Therapeutics Plc shares as an award (Form 4)
Traded Aug 18 to Oct 14, 2026 · Filed Oct 16, 2026
From Aug 18 to Oct 14, 2026, Bazemore Robert B (Director) received 17,777 Akari Therapeutics Plc shares as an award at US$7.90 for US$140K, leaving 22,759 shares. Filed Oct 16, 2026 (Form 4).
- Awarded
- 17,777 shares
- Price
- US$7.90
- Value
- US$140K
- Holding after
- 22,759 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | American Depositary Shares representing Ordinary Shares | Award | 13,100 | US$7.90 | 14,216 | Direct |
| Oct 5, 2026 | American Depositary Shares representing Ordinary Shares | Award | 4,677 | US$7.90 | 18,893 | Direct |
| Oct 14, 2026 | American Depositary Shares representing Ordinary Shares | Option exercise | 773 | US$0.00 | 19,666 | Direct |
| Oct 14, 2026 | American Depositary Shares representing Ordinary Shares | Option exercise | 3,093 | US$0.00 | 22,759 | Direct |
Source
Download original · View original at SEC